Decernotinib |
|
| Synonyms: (R)-2-((2-(1H-pyrrolo[2,3-b]pyridin-3-yl)pyrimidin-4-yl)amino)-2-methyl-N-(2,2,2-trifluoroethyl)butanamide;VX-509, VX509, VX 509, VRT-831509, VRT831509, VRT 831509; | |
| Cat. No.: D15000 | CAS No.: 944842-54-0 |
| MDL.: | Formula: C18H19F3N6O |
| F.W.329.38 | Purity: 99% |
| Storage: | |
| Size/Unit | Price | Qty | Availability | Price Total |
|---|---|---|---|---|
| 2mg | $325.00 | Enter qty and click checkbox |
 
|
$325.00 |
| Catalog Number： | D15000 | CAS No.: | 944842-54-0 | |
| MDL: | Formula: | C18H19F3N6O | ||
| F.W.: | 329.38 | Purity: | 99% | |
| Package: | Unit: | mg | ||
| Appearance: | M.P.: | |||
| B.P.: | Density: | |||
| Optical Rotation: | Refractive Index: | |||
| Solubility: | DMSO | Stability: | ||
| Storage: | Category: | Reference Standard | ||
| Reference: | Luc J. Farmer et. al., J. Med. Chem., 2015, 58 (18), pp 7195–7216 | |||
| Application: | Decernotinib is an oral, selective Janus kinase 3 (JAK3) inhibitor being developed by Vertex | |||
| Category: | Heterocycles, Nucleotides, Bases & Related Reagents, Pharmaceuticals, Intermediates & Fine Chemicals, | |||